GSK’s consumer healthcare company to be named Haleon

GlaxoSmithKline announced that its consumer healthcare company will be a standalone business named Haleon.

Advertisement

For the past eight years, GSK had been working toward the creation of an independent healthcare company, according to a Feb. 22 press release. Now, with the development of Haleon, that ambition is becoming a reality.  

Six things to know about Haleon: 

1. In June 2021, GSK announced its intent to demerge its consumer health unit from its pharmaceutical business.

2. Brands that will fall under Haleon will include Sensodyne toothpaste, Voltaren arthritis cream, Advil, Panadol, Excedrin, Centrum multivitamin, Tums, ChapStick, Nicorette and Nexium, according to Forbes.

3. The company will be deployed in 100 markets around the world.

4. Haleon is on track to be launched in mid-2022.

5. Haleon’s brand identity was developed with employees, healthcare practitioners and consumers.

6. Haleon will also have a new logo, stepping away from GSK’s bright orange and embracing a black and green style, Forbes reported.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.